Trial Details

COMPLETED
Basic Information
Clinical ID c1847
Identifier NCT02914262
Trial Title Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions IBD
Interventions DRUG: AKB-4924; OTHER: Placebo
Participant Information
Sponsor Aerpio Therapeutics
City Toronto
Country/Region Canada
Enrollment Criteria
Sex Requirement MALE
Age Requirement -
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-08-16
Primary Completion Date 2025-11-16
Completion Date 2025-01-17